CN1078814C - Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus - Google Patents

Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus Download PDF

Info

Publication number
CN1078814C
CN1078814C CN98111177A CN98111177A CN1078814C CN 1078814 C CN1078814 C CN 1078814C CN 98111177 A CN98111177 A CN 98111177A CN 98111177 A CN98111177 A CN 98111177A CN 1078814 C CN1078814 C CN 1078814C
Authority
CN
China
Prior art keywords
radix
parts
root
pill
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98111177A
Other languages
Chinese (zh)
Other versions
CN1228317A (en
Inventor
刘志勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98111177A priority Critical patent/CN1078814C/en
Publication of CN1228317A publication Critical patent/CN1228317A/en
Application granted granted Critical
Publication of CN1078814C publication Critical patent/CN1078814C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a traditional Chinese medicine for treating diabetes, particularly to a pill which can reduce the blood sugar. The present invention is characterized in that the pill is prepared from rhubarb, red sage root, rehmannia root, pueraria root, Chinese angelica root, astragalus root, coptis, fragrant solomonseal rhizome, kakuda figwort root, red peony root, moutan bark and ginseng according to a proportion of a formula. The preparation method of the pill comprises the following steps: utilizing each component medicine, grinding the component medicines into powder, and making pills by mixing medical powder with honey. A patient takes a pill at a time and three times a day. The present invention recovers the functions of pancreas to enable the pancreas to metabolize normally, treats both manifestation and root cause of diseases, rapidly treats symptoms and various complicating diseases, and enables the user to fundamentally get well with excellent curative effect. Through the observation of ten of thousands of cases, the effective rate of the present invention reaches 98 percent and the cure rate is over 95 percent. The present invention reaches to the advanced level in the industry.

Description

A kind of pill for the treatment of diabetes
The present invention relates to a kind of pill for the treatment of diabetes.
Diabetes, the traditional Chinese medical science claim to quench one's thirst, and are because a kind of chronic incretion disease that the relative or absolute deficiency of insulin causes.Sickness rate rises year by year in recent years, is common clinically difficult and complicated illness.Because cause of disease complexity, complication is many, so remain the medical circle a great problem until today.Usually the hypoglycemic medicine of selecting for use at present as glyburide, insoral, diabetes pill etc., only is conceived to " a falling " word, be purpose promptly with blood sugar lowering, glucose in urine, and ignored it another also be a basic problem, promptly how to recover islet function, make its secretion metabolism normal.Thereby these medicines are difficult to control or cure this disease, can't fundamentally cure fully, make numerous experts in a helpless situation for it, and this disease is judged to incurable disease.Numerous patients seek medical advice everywhere, expend wealth, and the disease feelings are not felt any better, and are seriously endangering people's physical and mental health.
The objective of the invention is to avoid above-mentioned weak point of the prior art, a kind of Jiangtangwan pill Chinese medicine that is used for the treatment of diabetes is provided.In the hope of by effectively improving patient's body function, treating both the principal and secondary aspects of a disease improves the cure rate of diabetes.
Purpose of the present invention is achieved through the following technical solutions.
The present invention has following composition:
Radix Et Rhizoma Rhei Radix Salviae Miltiorrhizae Radix Rehmanniae Radix Puerariae
Radix Angelicae Sinensis Radix Astragali Rhizoma Coptidis Rhizoma Polygonati Odorati
Radix Scrophulariae Radix Paeoniae Rubra Cortex Moutan Radix Ginseng.
Each ingredient in following share scope, fill a prescription (by weight):
Radix Et Rhizoma Rhei 50-100 part Radix Salviae Miltiorrhizae 40-90 part Radix Rehmanniae 40-80 part
Radix Puerariae 40-120 part Radix Angelicae Sinensis 30-50 part Radix Astragali 30-60 part
Rhizoma Coptidis 30-60 part Rhizoma Polygonati Odorati 30-50 part Radix Scrophulariae 20-50 part
Radix Paeoniae Rubra 20-40 part Cortex Moutan 20-40 part Radix Ginseng 10-30 part.
The medicament of below respectively distinguishing the flavor of is ground into the end, making pellets by mixing medical powder with honey, every ball nine grams.
In the above-mentioned medicament of respectively distinguishing the flavor of, Radix Et Rhizoma Rhei, Radix Paeoniae Rubra and Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling have the effect of blood fat reducing viscosity, microcirculation improvement.Because of diabetes belong to due to " blood stasis " more, make the islets of langerhans hematogenous blockage, fortuneization mistake power.The present invention recovers the islets of langerhans microcirculation by improving the islets of langerhans blood flow, regulates secretory function, can increase blood glucose utilization, store with and transform, reduce liver glycogen and decompose and heteroplasia.But Radix Ginseng tonifying QI to produce body fluid, blood sugar lowering, and have synergism with islets of langerhans.But Radix Astragali tonifying QI to promote blood circulation, the enhancing human body immunity ability prevents that liver glycogen from reducing, expansible blood vessel, it is capable to improve blood, and non-viable non-apoptotic cell is rejuvenated.The Radix Rehmanniae, Radix Scrophulariae heat clearing away enriching yin and nourishing kidney, blood sugar lowering.Cortex Moutan, Radix Puerariae clearing away heat and promoting production of body fluid, blood circulation promoting and blood stasis dispelling, blood vessel dilating, microcirculation improvement recovers the islets of langerhans activity, blood sugar lowering.But the Rhizoma Coptidis blood fat reducing, the expansion peripheral vessel promotes B cell regeneration and functional rehabilitation.All medicines have share adjusts congenital day after tomorrow of visceral dysfunction, balance whole body yang blood and qi body fluid wonderful.
This shows that compared with the prior art, the present invention sets about from recovering pancreatic functions, makes its metabolism normal, so can play the merit for the treatment of both the principal and secondary aspects of a disease, improves symptom and various complication rapidly, fundamentally rehabilitation, curative effect brilliance.
In tens thousand of examples of receiving treatment, curative effect is up to 98%, and cure rate can reach more than 60%, is industry advanced level.
By the following examples, the present invention is further described.
Embodiment 1:
In the present embodiment, specifically the amount of getting is as follows for each medicament of distinguishing the flavor of:
40 parts in 50 parts of Radix Rehmanniae of 50 parts of Radix Salviae Miltiorrhizaes of Radix Et Rhizoma Rhei
30 parts of 30 parts of Radixs Astragali of 50 parts of Radix Angelicae Sinensis of Radix Puerariae
20 parts of 30 portions of Radix Scrophulariae of 30 portions of Rhizoma Polygonati Odorati of Rhizoma Coptidis
10 parts of 20 parts of Radix Ginsengs of 30 parts of Cortex Moutans of Radix Paeoniae Rubra.
Be ground into the end, making pellets by mixing medical powder with honey, every clothes one ball, every day three times.
Embodiment 2:
In the present embodiment, specifically the amount of getting is as follows for each medicament of distinguishing the flavor of:
80 parts in 80 parts of Radix Rehmanniae of 90 parts of Radix Salviae Miltiorrhizaes of Radix Et Rhizoma Rhei
50 parts of 50 parts of Radixs Astragali of 90 parts of Radix Angelicae Sinensis of Radix Puerariae
40 parts of 50 portions of Radix Scrophulariae of 50 portions of Rhizoma Polygonati Odorati of Rhizoma Coptidis
30 parts of 30 parts of Radix Ginsengs of 40 parts of Cortex Moutans of Radix Paeoniae Rubra.
Be ground into the end, making pellets by mixing medical powder with honey, every clothes one ball, every day three times.
Case 1:
Zhang Weixian, the man, 67 years old, Temple of the Dragon King town, Daming County, Hebei province, western Cao Kou village, ill at the beginning of 1997, xerostomia, polydipsia, throat pain, polyphagia, weak.Through chemical examination, blood glucose<16.3 〉, glucose in urine<+++after the present invention according to every day 3 times, the consumption of each 1 ball was promptly cured transference cure in 45 days.Again through the chemical examination,

Claims (3)

1, a kind of pill for the treatment of diabetes is characterized in that the weight of its curative effect component consists of:
Radix Et Rhizoma Rhei 50-100 part Radix Salviae Miltiorrhizae 40-90 part Radix Rehmanniae 40-80 part
Radix Puerariae 40-120 part Radix Angelicae Sinensis 30-50 part Radix Astragali 30-60 part
Rhizoma Coptidis 30-60 part Rhizoma Polygonati Odorati 30-50 part Radix Scrophulariae 20-50 part
Radix Paeoniae Rubra 20-40 part Cortex Moutan 20-40 part Radix Ginseng 10-30 part.
2, pill according to claim 1 is characterized in that the weight of its curative effect component consists of:
40 parts in 50 parts of Radix Rehmanniae of 50 parts of Radix Salviae Miltiorrhizaes of Radix Et Rhizoma Rhei
30 parts of 30 parts of Radixs Astragali of 50 parts of Radix Angelicae Sinensis of Radix Puerariae
20 parts of 30 portions of Radix Scrophulariae of 30 portions of Rhizoma Polygonati Odorati of Rhizoma Coptidis
10 parts of 20 parts of Radix Ginsengs of 30 parts of Cortex Moutans of Radix Paeoniae Rubra.
3, pill according to claim 1 is characterized in that the weight of its curative effect component consists of:
80 parts in 80 parts of Radix Rehmanniae of 90 parts of Radix Salviae Miltiorrhizaes of Radix Et Rhizoma Rhei
50 parts of 50 parts of Radixs Astragali of 90 parts of Radix Angelicae Sinensis of Radix Puerariae
40 parts of 50 portions of Radix Scrophulariae of 50 portions of Rhizoma Polygonati Odorati of Rhizoma Coptidis
30 parts of 30 parts of Radix Ginsengs of 40 parts of Cortex Moutans of Radix Paeoniae Rubra.
CN98111177A 1998-03-11 1998-03-11 Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus Expired - Fee Related CN1078814C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98111177A CN1078814C (en) 1998-03-11 1998-03-11 Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98111177A CN1078814C (en) 1998-03-11 1998-03-11 Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus

Publications (2)

Publication Number Publication Date
CN1228317A CN1228317A (en) 1999-09-15
CN1078814C true CN1078814C (en) 2002-02-06

Family

ID=5221175

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98111177A Expired - Fee Related CN1078814C (en) 1998-03-11 1998-03-11 Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus

Country Status (1)

Country Link
CN (1) CN1078814C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100500669C (en) * 2004-12-10 2009-06-17 山东大学 Salviolic acid berberine compound salt, its preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
湖南中医东志1989/5(3):8 1989.1.1 申健 三消汤治疗糖尿病一附365例疗效观察 *

Also Published As

Publication number Publication date
CN1228317A (en) 1999-09-15

Similar Documents

Publication Publication Date Title
CN102274447B (en) Medicinal composition for treating diabetes
CN1742939B (en) Medicine for treating pulmonary fibrosis and preparing method
CN101708302B (en) Chinese medicinal preparation for treating diabetes and preparation method thereof
CN103566350A (en) Pharmaceutical composition having blood sugar reducing effect
CN1301737C (en) Chinese medicinal preparation for treating diabetes and its preparation method
CN102462834A (en) Medicinal composition for controlling blood sugar of diabetic
CN1332702C (en) Medicine for treating psoriasis
CN103055198A (en) Medicine for treating diabetes mellitus and preparation method thereof
CN102488830B (en) Pharmaceutical composition for lowering blood sugar
CN1078814C (en) Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus
CN1329067C (en) Traditional Chinese medicine prepn. for treating diabetes
CN100493590C (en) Astragalus leech collateral clearing capsule
CN103007159B (en) Chinese medicinal preparation for correcting pancreas islet function
CN1066332C (en) Hypoglycemic compound capsule
CN102552520B (en) Blood circulation-promoting and pain-stopping medicament and preparation process and application thereof
CN105125885B (en) It is a kind of to be used to prevent Chinese medicine composition of diabetes and preparation method thereof
CN1103598C (en) Chinese medicine for treating diabetes and preparation method therefor
CN1263488C (en) Capsule of dual gen-sengs and preparing technique
CN101843775A (en) Chinese medicament for treating diabetic nephropathy
CN100369621C (en) Medicine for treating diabetes
CN1306830A (en) Medicine for treating Type-11 diabetes
CN1686304A (en) Medicinal preparation for treating diabetes and its preparation method
CN1602921A (en) Medicine for treating diabetes and its preparing process
CN101843816B (en) Chinese medicament for treating chronic nephritis
CN101972434B (en) Traditional Chinese medicine for treating diabetes mellitus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1068605

Country of ref document: HK

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Xiao Yun

Document name: payment instructions

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Xiao Yun

Document name: Notification of Termination of Patent Right

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee